This rat monoclonal antibody was raised against synthetic monomeric human Amyloid-beta peptide and is specific for human Amyloid beta.
The progressive accumulation of extracellular amyloid plaques in the brain is a common hallmark of Alzheimer's disease. Forms of Amyloid beta phosphorylated at serine residue 8 have increased propensity to form toxic aggregates as compared to non-phosphorylated species.
From the laboratory of Jochen Walter, PhD, University of Bonn.
|Immunogen:||Synthetic monomeric human Amyloid-beta peptide|
|Buffer:||PBS with 0.02% Proclin 300|
|Tested Applications:||WB (1:500), IHC (1:200-1000), IP (1:100) ELISA (Use as an assay dependent dilution)|
If you publish research with this product, please let us know so we can cite your paper.